BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28033393)

  • 1. Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study.
    Parsons E; Otieno JA; Ong'echa JM; Nixon CE; Vulule J; Münz C; Stewart VA; Moormann AM
    PLoS One; 2016; 11(12):e0167841. PubMed ID: 28033393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses.
    Moormann AM; Heller KN; Chelimo K; Embury P; Ploutz-Snyder R; Otieno JA; Oduor M; Münz C; Rochford R
    Int J Cancer; 2009 Apr; 124(7):1721-6. PubMed ID: 19089927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens.
    Snider CJ; Cole SR; Chelimo K; Sumba PO; Macdonald PD; John CC; Meshnick SR; Moormann AM
    PLoS One; 2012; 7(3):e31753. PubMed ID: 22427806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.
    Piriou E; Asito AS; Sumba PO; Fiore N; Middeldorp JM; Moormann AM; Ploutz-Snyder R; Rochford R
    J Infect Dis; 2012 Mar; 205(6):906-13. PubMed ID: 22301635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children.
    Moormann AM; Chelimo K; Sumba PO; Tisch DJ; Rochford R; Kazura JW
    J Infect Dis; 2007 Mar; 195(6):799-808. PubMed ID: 17299709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between IL-10, IFN-γ, IL-17A and PD-1 Expressing EBNA1-Specific CD4
    Forconi CS; Mulama DH; Saikumar Lakshmi P; Foley J; Otieno JA; Kurtis JD; Berg LJ; Ong'echa JM; Münz C; Moormann AM
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
    Kaymaz Y; Oduor CI; Aydemir O; Luftig MA; Otieno JA; Ong'echa JM; Bailey JA; Moormann AM
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer.
    Mulama DH; Bailey JA; Foley J; Chelimo K; Ouma C; Jura WG; Otieno J; Vulule J; Moormann AM
    Int J Cancer; 2014 Feb; 134(3):645-53. PubMed ID: 23832374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya.
    Redmond LS; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Masalu N; Kawira E; Otim I; Legason ID; Dhudha H; Ayers LW; Bhatia K; Goedert JJ; Mbulaiteye SM
    Malar J; 2020 Jul; 19(1):239. PubMed ID: 32718346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children.
    Muriuki BM; Forconi CS; Oluoch PO; Bailey JA; Ghansah A; Moormann AM; Ong'echa JM
    Sci Rep; 2021 May; 11(1):11343. PubMed ID: 34059753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of TCR-gammadelta+ cells in endemic Burkitt's lymphoma.
    Futagbi G; Welbeck JE; Tetteh JK; Hviid L; Akanmori BD
    Malar J; 2007 May; 6():69. PubMed ID: 17521425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies.
    Derkach A; Otim I; Pfeiffer RM; Onabajo OO; Legason ID; Nabalende H; Ogwang MD; Kerchan P; Talisuna AO; Ayers LW; Reynolds SJ; Nkrumah F; Neequaye J; Bhatia K; Theander TG; Prokunina-Olsson L; Turner L; Goedert JJ; Lavstsen T; Mbulaiteye SM
    EBioMedicine; 2019 Jan; 39():358-368. PubMed ID: 30579868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation.
    Chattopadhyay PK; Chelimo K; Embury PB; Mulama DH; Sumba PO; Gostick E; Ladell K; Brodie TM; Vulule J; Roederer M; Moormann AM; Price DA
    J Virol; 2013 Feb; 87(3):1779-88. PubMed ID: 23175378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
    Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
    Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and regulatory T cells in Egyptian paediatric patients with acute B lymphoblastic leukaemia.
    Ateyah ME; Hashem ME; Abdelsalam M
    J Clin Pathol; 2017 Feb; 70(2):120-125. PubMed ID: 27458150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.
    Buckle G; Maranda L; Skiles J; Ong'echa JM; Foley J; Epstein M; Vik TA; Schroeder A; Lemberger J; Rosmarin A; Remick SC; Bailey JA; Vulule J; Otieno JA; Moormann AM
    Int J Cancer; 2016 Sep; 139(6):1231-40. PubMed ID: 27136063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.
    Kaymaz Y; Oduor CI; Yu H; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
    Mol Cancer Res; 2017 May; 15(5):563-576. PubMed ID: 28465297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poorly cytotoxic terminally differentiated CD56
    Forconi CS; Cosgrove CP; Saikumar-Lakshmi P; Nixon CE; Foley J; Ong'echa JM; Otieno JA; Alter G; Münz C; Moormann AM
    Blood Adv; 2018 May; 2(10):1101-1114. PubMed ID: 29764843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the Combined Effect of Epstein-Barr Virus and
    Aguilar R; Casabonne D; O'Callaghan-Gordo C; Vidal M; Campo JJ; Mutalima N; Angov E; Dutta S; Gaur D; Chitnis CE; Chauhan V; Michel A; de Sanjosé S; Waterboer T; Kogevinas M; Newton R; Dobaño C
    Front Immunol; 2017; 8():1284. PubMed ID: 29123514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma.
    Muriuki BM; Forconi CS; Kirwa EK; Maina TK; Ariera BO; Bailey JA; Ghansah A; Moormann AM; Ong'echa JM
    PLoS One; 2023; 18(8):e0275046. PubMed ID: 37647275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.